Coronary artery disease in cardiac allografts: association with depleted arteriolar tissue plasminogen activator
Labarrere, C.A.; Pitts, D.; Nelson, D.R.; Faulk, W.P.
Transplantation Proceedings 27(3): 1941-1943
1995
ISSN/ISBN: 0041-1345 PMID: 7792844 Document Number: 449829
Document emailed within 1 workday
Related Documents
Kobayashi, Y.; Fukuo, Y.; Shibuya, T.; Terashi, A. 1990: The correlation between the activity of tissue plasminogen activator (TPA), levels of tissue plasminogen activator inhibitor (PAI-1) antigen and serum lipids in healthy subjects Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 27(5): 578-583Chen, Z.Y. 1993: A study on the circadian variation of tissue-type plasminogen activator and its rapid inhibitor in patients with coronary heart disease Zhonghua Xin Xue Guan Bing Za Zhi 21(3): 163-164; 188
Han, X.M.; Chen, Z.Q.; Mao, H.M. 1990: Determination of plasma tissue type plasminogen activator and plasminogen activator inhibitor activity in patients with ischemic stroke Zhonghua Nei Ke Za Zhi 29(9): 544-546; 575-576
Habib, S.S.; Abdel Gader, A.G.M.; Kurdi, M.I.; Suriya, M.O.; Al Aseri, Z. 2012: Tissue plasminogen activator and plasminogen activator inhibitor-1 levels in patients with acute myocardial infarction and unstable angina JPMA. Journal of the Pakistan Medical Association 62(7): 681-685
Yamada, R.; Yamada, S.; Ishii, A.; Tane, S. 1993: Evaluation of tissue plasminogen activator and plasminogen activator inhibitor-1 in blood obtained from patients of idiopathic central serous chorioretinopathy Nippon Ganka Gakkai Zasshi 97(8): 955-960
De Moerloose, P.; Mermillod, N.; Amiral, J.; Reber, G. 1998: Thrombomodulin levels during normal pregnancy, at delivery and in the postpartum: comparison with tissue-type plasminogen activator and plasminogen activator inhibitor-1 Thrombosis and Haemostasis 79(3): 554-556
Fukao, H.; Yamamoto, K.; Matsuo, O. 1991: Levels of tissue-type plasminogen activator and plasminogen activator inhibitor 1 in disseminated intravascular coagulation syndrome Rinsho Byori. Japanese Journal of Clinical Pathology 39(7): 720-726
Shiba, E.; Kobayashi, T.; Yayoi, E.; Takatsuka, Y.; Koyama, H.; Takai, S.; Mori, T. 1992: Measurement of plasminogen activator and plasminogen activator inhibitor in breast cancer tissue: preliminary report Nihon Geka Gakkai Zasshi 93(1): 109
Wallnöfer, A.E.; van Griensven, J.M.; Schoemaker, H.C.; Cohen, A.F.; Lambert, W.; Kluft, C.; Meijer, P.; Kooistra, T. 1993: Effect of isotretinoin on endogenous tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) in humans Thrombosis and Haemostasis 70(6): 1005-1008
Yang, L.; Tian, X.; Guo, R.; Liu, H.; Qi, F.; Ye, J. 2014: Relationship between atherosclerotic plaque characteristics and extracellular matrix metalloproteinase inducer and urokinase-type plasminogen activator in patients with coronary artery disease Zhonghua Xin Xue Guan Bing Za Zhi 42(9): 740-743
Glas-Greenwalt, P.; Hall, J.M.; Panke, T.W.; Kant, K.S.; Allen, C.M.; Pollak, V.E. 1986: Fibrinolysis in health and disease: abnormal levels of plasminogen activator, plasminogen activator inhibitor, and protein C in thrombotic thrombocytopenic purpura Journal of Laboratory and Clinical Medicine 108(5): 415-422
Von Romatowski, H.J.; Henze, T.; Tebbe, U. 1988: Recanalization of basilar artery occlusion with tissue-type plasminogen activator Deutsche Medizinische Wochenschrift 113(15): 616
Nelles, L.; Lijnen, H.R.; Van Nuffelen, A.; Demarsin, E.; Collen, D. 1990: Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA) Thrombosis and Haemostasis 64(1): 53-60
Hirschfield, G. 2001: Effects of fluvastatin and bezafibrate combination on plasma fibrinogen, t-plasminogen activator inhibitor and C reactive protein levels in coronary artery disease patients with mixed hyperlipidaemia (FACT Study)--a rebuttal Thrombosis and Haemostasis 85(1): 189-190
Fujii, S.; Lucore, C.L.; Hopkins, W.E.; Billadello, J.J.; Sobel, B.E. 1990: Induction of synthesis of plasminogen activator inhibitor type-1 by tissue-type plasminogen activator in human hepatic and endothelial cells Thrombosis and Haemostasis 64(3): 412-419
Lehmkuhl, H.; Horn, C.; von der Driesch, P.; Kämmerer, U.; Müller, T.; von der Emde, J.; Olbrich, H.G.; Kunkel, B.; Bachmann, K. 1996: Analysis of adhesion molecules in myocardial biopsies of cardiac allografts and coronary artery disease with CABG Journal of Cardiovascular Surgery 37(6 Suppl 1: 65-70
Ardashev, V.N.; Sokolianskiĭ, N.V.; Bystrov, V.V. 2000: Fibrinolytic therapy of patients with pulmonary artery thromboembolism by tissue plasminogen activator and streptokinase preparations Klinicheskaia Meditsina 78(12): 28-30
Rość, D.; Drewniak, W.; Kotschy, M.; Graczykowska-Koczorowska, A.; Raukuć, D. 1997: Plasminogen tissue activator and plasminogen tissue inhibitor in type Ii diabetes Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 2(7): 24-25
Ladenvall, P.; Wall, U.; Jern, S.; Jern, C. 2000: Identification of eight novel single-nucleotide polymorphisms at human tissue-type plasminogen activator (t-PA) locus: association with vascular t-PA release in vivo Thrombosis and Haemostasis 84(2): 150-155
Młynarska, A.; Waszyrowski, T.; Kasprzak, J.ła.D. 2007: Plasminogen activator inhibitor-1 (PAI-1): pathogenetic role in coronary disease Kardiologia Polska 65(9): 1109-1114